Calliditas Therapeutics AB (publ)
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -1.55 | -100% |
| P/S |
|
12.89 | 33.75 | -61.82% |
|
|
| P/BV |
|
46.46 | 4.82 | 864.36% |
|
|
| P/FCF |
|
-1 | 61 | -101.64% |
|
|
| Ev/Ebitda |
|
-42.31 | -22.17 | 90.81% |
|
|
| Ev/S |
|
12.89 | 22.56 | -42.85% |
|
|
| Ev/FCF |
|
-34.78 | 68.75 | -150.58% |
|
|
| E/P |
|
-1.04 | 0.0178 | -5951.35% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-30.48 | 4.98 | -712.33% | -8734.1 | -99.65% |
| ROE |
|
-139.24 | 9.61 | -1548.67% |
|
|
| ROA |
|
-24.53 | 0.3443 | -7225.14% |
|
|
| ROIC |
|
-48.13 | 7.63 | -730.44% |
|
|
| ROS |
|
-38.63 | -25.17 | 53.48% |
|
|
| ROCE |
|
-114.81 | 15.35 | -847.94% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2.59 | -3.68 | -29.58% | -2.02 | +28.43% |
| Nеt Debt/Ebitda |
|
-0.0147 | -3.44 | -99.57% |
|
|
| Debt/Ratio |
|
0.5009 | 0.1985 | 152.38% |
|
|
| Debt/Equity |
|
7.1 | 1.66 | 327.11% |
|
|
| Debt/Net Income |
|
-2.04 | 10.32 | -119.78% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
552.98 | -56.89 | -1072.02% | ||
| Growth impulse Ebitda in 5 years |
|
1363.6 | -54.68 | -2593.78% | ||
| Growth impulse Net Income in 5 years |
|
1330.98 | -58.33 | -2381.81% | ||
| Growth impulse FCF in 5 years |
|
413.15 | -49.48 | -934.98% | ||
| Growth impulse EPS in 5 years |
|
5543.8 | -32.41 | -17205.21% |
IP Score
4.16/10
